$125 | Single User
$250 | Site License
$375 | Enterprise License

AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review [Report Updated: 12-07-2017]

Published by Global Data: 12 Jul 2017 | 103713 | In Stock

Introduction

AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes novel therapies for the treatment of pain. The company’s lead product candidate, DSUVIA (known as ARX-04 outside the US), is a single sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. It pipeline also includes ZALVISO, a drug and device combination product for management of moderate to severe acute pain in adults. AcelRx incorporates non-invasive, sublingual formulation technology to deliver highly drugs of its product candidates. The company commercializes ZALVISO under license agreement with Grunenthal in the European Union countries, Switzerland, Liechtenstein, Iceland, Norway, and Australia. AcelRx is headquartered in Redwood City, California, the US.

AcelRx Pharmaceuticals Inc Key Recent Developments

May 08,2017: AcelRx Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update

Mar 02,2017: AcelRx Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results

Feb 16,2017: AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer

Nov 01,2016: AcelRx Pharmaceuticals Provides Corporate Update and Reports Third Quarter and Nine Months 2016 Financial Results

Jul 28,2016: AcelRx Pharmaceuticals Provides Corporate Update and Reports Second Quarter and Six Months 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review [Report Updated: 12-07-2017]

  • Table of Contents

    Table of Contents 3

    List of Tables 5

    List of Figures 5

    Section 1 - About the Company 6

    AcelRx Pharmaceuticals Inc - Key Facts 6

    AcelRx Pharmaceuticals Inc - Key Employees 7

    AcelRx Pharmaceuticals Inc - Major Products and Services 8

    AcelRx Pharmaceuticals Inc - History 9

    AcelRx Pharmaceuticals Inc - Company Statement 10

    AcelRx Pharmaceuticals Inc - Locations And Subsidiaries 14

    Head Office 14

    Other Locations & Subsidiaries 14

    Section 2 – Company Analysis 15

    AcelRx Pharmaceuticals Inc - Business Description 15

    AcelRx Pharmaceuticals Inc - Corporate Strategy 16

    AcelRx Pharmaceuticals Inc - SWOT Analysis 17

    SWOT Analysis - Overview 17

    AcelRx Pharmaceuticals Inc - Strengths 17

    AcelRx Pharmaceuticals Inc - Weaknesses 18

    AcelRx Pharmaceuticals Inc - Opportunities 19

    AcelRx Pharmaceuticals Inc - Threats 20

    AcelRx Pharmaceuticals Inc - Key Competitors 21

    Section 3 – Company Financial Ratios 22

    Financial Ratios - Capital Market Ratios 22

    Financial Ratios - Annual Ratios 23

    Performance Chart 25

    Financial Performance 25

    Financial Ratios - Interim Ratios 26

    Financial Ratios - Ratio Charts 27

    Section 4 – Company’s Lifesciences Financial Deals and Alliances 28

    AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28

    AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29

    AcelRx Pharmaceuticals Inc, Recent Deals Summary 30

    Section 5 – Company’s Recent Developments 31

    May 08, 2017: AcelRx Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update 31

    Mar 02, 2017: AcelRx Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results 33

    Feb 16, 2017: AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer 35

    Nov 01, 2016: AcelRx Pharmaceuticals Provides Corporate Update and Reports Third Quarter and Nine Months 2016 Financial Results 36

    Jul 28, 2016: AcelRx Pharmaceuticals Provides Corporate Update and Reports Second Quarter and Six Months 2016 Financial Results 38

    May 02, 2016: AcelRx Pharmaceuticals Provides Corporate Update and Reports First Quarter 2016 Financial Results 41

    Mar 29, 2016: AcelRx Pharmaceuticals Names Howard B. Rosen as Chief Executive Officer and Provides Update on Clinical Development Activities and Corporate Priorities for 2016 43

    Mar 07, 2016: AcelRx Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2015 Financial Results 44

    Section 6 – Appendix 46

    Methodology 46

    Ratio Definitions 46

    About GlobalData 50

    Contact Us 50

    Disclaimer 50

List Of Tables
in AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review [Report Updated: 12-07-2017]

List of Tables

AcelRx Pharmaceuticals Inc, Key Facts 6

AcelRx Pharmaceuticals Inc, Key Employees 7

AcelRx Pharmaceuticals Inc, Major Products and Services 8

AcelRx Pharmaceuticals Inc, History 9

AcelRx Pharmaceuticals Inc, Subsidiaries 14

AcelRx Pharmaceuticals Inc, Key Competitors 21

AcelRx Pharmaceuticals Inc, Ratios based on current share price 22

AcelRx Pharmaceuticals Inc, Annual Ratios 23

AcelRx Pharmaceuticals Inc, Annual Ratios (Cont...1) 24

AcelRx Pharmaceuticals Inc, Interim Ratios 26

AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28

AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29

AcelRx Pharmaceuticals Inc, Recent Deals Summary 30

Currency Codes 46

Capital Market Ratios 46

Equity Ratios 47

Profitability Ratios 47

Cost Ratios 48

Liquidity Ratios 48

Leverage Ratios 49

Efficiency Ratios 49

List Of Figures, Charts and Diagrams
in AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review [Report Updated: 12-07-2017]

List of Figures

AcelRx Pharmaceuticals Inc, Performance Chart (2012 - 2016) 25

AcelRx Pharmaceuticals Inc, Ratio Charts 27

AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28

AcelRx Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 29

Additional Details

Publisher

Global Data

Publisher Information

Reference

103713 | GDPH26475FSA

Number of Pages

50

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
AcelRx Pharmaceuticals, Inc. (ACRX) - Medical Equipment - Deals and Alliances Profile
SummaryAcelRx Pharmaceuticals, Inc. (AcelRx) is a pharmaceutical company that focuses on the develop...
20 Jul 2016 by Global Data USD $250 More Info
AcelRx Pharmaceuticals, Inc. (ACRX) - Financial and Strategic SWOT Analysis Review
SummaryAcelRx Pharmaceuticals, Inc. (AcelRx) is a pharmaceutical company that focuses on the develop...
11 Jul 2016 by Global Data USD $300 More Info
AcelRx Pharmaceuticals, Inc. (ACRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAcelRx Pharmaceuticals, Inc. (AcelRx) is a pharmaceutical company that develops sublingual fo...
05 May 2016 by Global Data USD $250 More Info
AcelRx Pharmaceuticals, Inc. (ACRX) - Financial and Strategic SWOT Analysis Review
SummaryAcelRx Pharmaceuticals, Inc. (AcelRx) is a pharmaceutical company that develops therapies. Th...
15 Apr 2016 by Global Data USD $300 More Info
AcelRx Pharmaceuticals, Inc. (ACRX) - Medical Equipment - Deals and Alliances Profile
SummaryAcelRx Pharmaceuticals, Inc. (AcelRx) is a pharmaceutical company that develops therapies. Th...
07 Apr 2016 by Global Data USD $250 More Info
AcelRx Pharmaceuticals, Inc. (ACRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAcelRx Pharmaceuticals, Inc. (AcelRx) is a pharmaceutical company that develops therapies. Th...
08 Mar 2016 by Global Data USD $250 More Info
AcelRx Pharmaceuticals, Inc. (ACRX) - Medical Equipment - Deals and Alliances Profile
SummaryAcelRx Pharmaceuticals, Inc. (AcelRx) is a pharmaceutical company that develops therapies. Th...
23 Feb 2016 by Global Data USD $250 More Info
AcelRx Pharmaceuticals, Inc. (ACRX) - Financial and Strategic SWOT Analysis Review
SummaryAcelRx Pharmaceuticals, Inc. (AcelRx) is a pharmaceutical company that develops therapies. Th...
09 Jan 2016 by Global Data USD $300 More Info
AcelRx Pharmaceuticals, Inc. (ACRX) - Financial and Strategic SWOT Analysis Review
SummaryAcelRx Pharmaceuticals, Inc. (AcelRx) is a pharmaceutical company that develops therapies. Th...
08 Nov 2015 by Global Data USD $300 More Info
AcelRx Pharmaceuticals, Inc. (ACRX) - Medical Equipment - Deals and Alliances Profile
SummaryAcelRx Pharmaceuticals, Inc. (AcelRx) is a pharmaceutical company that develops therapies. Th...
15 Oct 2015 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review [Report Updated: 12-07-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data